Revvity RVTY Diagnostics — Restructuring and Other Costs (Income)
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Revvity in its filing.
Tagged under the XBRL concept us-gaap:RestructuringCosts.
The official record: Revvity’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Revvity's diagnostics — restructuring and other costs (income).
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Revvity's diagnostics — restructuring and other costs (income)?
- Revvity (RVTY) reported diagnostics — restructuring and other costs (income) of $7.55M in Q1 2026.
- How has Revvity's diagnostics — restructuring and other costs (income) changed year-over-year?
- Revvity's diagnostics — restructuring and other costs (income) increased by 5495.6% year-over-year, from $135K to $7.55M.
- What does diagnostics — restructuring and other costs (income) mean?
- One-time costs or gains associated with reorganizing the diagnostics business segment.
- How do you interpret diagnostics — restructuring and other costs (income)?
- High costs suggest significant operational transformation, while consistent low levels indicate organizational stability.
- How does diagnostics — restructuring and other costs (income) compare across companies?
- Commonly reported by large-cap industrial and healthcare companies undergoing periodic operational optimization.